SlideShare ist ein Scribd-Unternehmen logo
1 von 18
An opportunistic pathogen isolated from
the gut of an obese human causes
obesity in germfree mice




                                             Lisa
                       Luna Medical Primary Care
Case

• weight 174.8 kg,
• body mass index 58.8 kgm2
• suffering from diabetes, hypertension and other serious
  metabolic deteriorations

• on a diet composed of whole grains, traditional Chinese
  medicinal foods and prebiotics

• lost 30.1 kg after 9 weeks, and 51.4 kg after 23 weeks
• Amelioration of hyperinsulinemia, hyperglycemia and
  hypertension until most metabolic parameters improved
  to normal ranges
How does it happen?
• Biomedical Indicator
Key Point----Enterobacter
a genus of opportunistic, endotoxin producing
Pathogens, made up 35% of the gut bacteria in a
morbidly obese volunteer

After 9 weeks on the WTP diet*, this Enterobacter
population in the volunteer’s gut reduced to 1.8%, and
became undetectable by the end of the 23-week trial
*WTP Diet :whole grains, traditional Chinese medicine and prebiotics
Hypothesis

The endotoxin producing Enterobacter
population may have a causative role in the
metabolic deteriorations of its human host
Animal Studies
Animal:
Germfree (GF) male C57BL/6J mice*
  *germfree mice are resistant to HFD-induced obesity
Clinical isolation:
• Strain Enterobacter cloacae B29 isolated from the volunteer’s gut
• and nearest neighbor as E.cloacae subsp. cloacae ATCC 13047
Process:
Inoculation of B29 and Luria–Bertani (LB) into GF mice
Feed:
• normal chow diet (NCD) or
• High fat diet(HFD)
(continued)
4 groups:
•   NCD+B29
•   NCD+LB
•   HFD+B29
•   HFD+LB

data collected at the end of 16 weeks after inoculation
• Body weight
• mass of epididymal, mesenteric, subcutaneous inguinal and retroperitoneal
  fat pad;
• oral glucose tolerance test (OGTT) and areas under the curve (AUC) for the
  plasma glucose;
• serum 2h post load insulin;
• enzyme-linked immunosorbent assay (ELISA) analysis of serum LPS-binding
  protein (LBP);
• serum amyloid A (SAA);
• adiponectin corrected for bodyweight
Body weight after 16 weeks of experiment
Fat pad after 16 weeks of experiment
Blood Glucose level after 16 weeks of experiment
Conclusion from the data collected

• The HFD+B29 gnotobiotic mice developed the
  most significant insulin resistant phenotype
  and body gain and other characteristics of
  obesity
• The NCD+B29or NCD+LB both remained lean
  throughout the trial
Serum LPS-binding protein after 16 weeks




*B29 was the only LPS producer in the gnotobiotic-mouse gut
Conclusion from the LBP level after 16 weeks experiment

 • The serum LPS-binding protein was significantly higher in the
   HFD+B29 gnotobiotic mice than in the NCD+B29

 • increased serum–endotoxin load in the HFD+B29 gnotobiotic
   mice could only come from B29.
Serum SAA and adiponection level after the 16 weeks




HFD+B29 mice had the greatest increase in systemic
inflammation
Conclusion of the study
Overgrowth of an endotoxin producing gut
bacterium is a contributing factor to, rather than
a consequence of, the metabolic deteriorations
in its human host
Strength of the study

• for the first time, established a gnotobiotic-mouse obesity
  model combining HFD with a human-originated endotoxin
  producer
• identify more such obesity-inducing bacteria from various
  human populations
• develop new strategies for reducing the devastating epidemic
  of metabolic diseases
Several question remains uncertain

• Study is conducted for 16 weeks, it’s uncertain if the
  gut pathogen from the obese functions the similar
  way in a long term.
• B29 is probably not the only contributor to human
  obesity in vivo.
• More case study is required to replicate the
  experiments
Thank You!

We Appreciate Your Patience

Weitere ähnliche Inhalte

Was ist angesagt?

Gut microbiomes as pharmacological target
Gut microbiomes as pharmacological targetGut microbiomes as pharmacological target
Gut microbiomes as pharmacological targetAdeel Zafar
 
Insulin and HGH production using rDNA technology
Insulin and HGH production using rDNA technologyInsulin and HGH production using rDNA technology
Insulin and HGH production using rDNA technologyMrinal Vashisth
 
Screening method of herbal drugs & formulation
Screening method of herbal drugs & formulationScreening method of herbal drugs & formulation
Screening method of herbal drugs & formulationKUNAL KELZARKAR
 
Surgical nutrition
Surgical nutritionSurgical nutrition
Surgical nutritionCrazyMed
 
Industrial Manufacturing of Insulin,
Industrial Manufacturing of Insulin, Industrial Manufacturing of Insulin,
Industrial Manufacturing of Insulin, Fawad Akram
 
Rusham presentation on human insulin
Rusham presentation on human insulinRusham presentation on human insulin
Rusham presentation on human insulinRusham Das
 
Insulin by Dr. Anurag Yadav
Insulin by Dr. Anurag YadavInsulin by Dr. Anurag Yadav
Insulin by Dr. Anurag YadavDr Anurag Yadav
 
Metabolic Syndrome is Teduced in C57BL/6J Mice Fed High-fat Diets Supplemente...
Metabolic Syndrome is Teduced in C57BL/6J Mice Fed High-fat Diets Supplemente...Metabolic Syndrome is Teduced in C57BL/6J Mice Fed High-fat Diets Supplemente...
Metabolic Syndrome is Teduced in C57BL/6J Mice Fed High-fat Diets Supplemente...PatriciaRay5
 
Health promoting properties encoded within fermented food microbiota
Health promoting properties encoded within fermented food microbiotaHealth promoting properties encoded within fermented food microbiota
Health promoting properties encoded within fermented food microbiotaLaura Berry
 
Adipose tissue in immunity
Adipose tissue in immunityAdipose tissue in immunity
Adipose tissue in immunityvidyabiochemist
 
Insulin, glucagon and diabetes mellitus
Insulin, glucagon and diabetes mellitusInsulin, glucagon and diabetes mellitus
Insulin, glucagon and diabetes mellitusLubna Abu Alrub,DDS
 

Was ist angesagt? (18)

Slides18
Slides18Slides18
Slides18
 
Adeli 1 8
Adeli 1 8Adeli 1 8
Adeli 1 8
 
Gut microbiomes as pharmacological target
Gut microbiomes as pharmacological targetGut microbiomes as pharmacological target
Gut microbiomes as pharmacological target
 
Insulin and HGH production using rDNA technology
Insulin and HGH production using rDNA technologyInsulin and HGH production using rDNA technology
Insulin and HGH production using rDNA technology
 
Leaky gut
Leaky gutLeaky gut
Leaky gut
 
Screening method of herbal drugs & formulation
Screening method of herbal drugs & formulationScreening method of herbal drugs & formulation
Screening method of herbal drugs & formulation
 
Surgical nutrition
Surgical nutritionSurgical nutrition
Surgical nutrition
 
Industrial Manufacturing of Insulin,
Industrial Manufacturing of Insulin, Industrial Manufacturing of Insulin,
Industrial Manufacturing of Insulin,
 
Rusham presentation on human insulin
Rusham presentation on human insulinRusham presentation on human insulin
Rusham presentation on human insulin
 
Insulin by Dr. Anurag Yadav
Insulin by Dr. Anurag YadavInsulin by Dr. Anurag Yadav
Insulin by Dr. Anurag Yadav
 
Metabolic Syndrome is Teduced in C57BL/6J Mice Fed High-fat Diets Supplemente...
Metabolic Syndrome is Teduced in C57BL/6J Mice Fed High-fat Diets Supplemente...Metabolic Syndrome is Teduced in C57BL/6J Mice Fed High-fat Diets Supplemente...
Metabolic Syndrome is Teduced in C57BL/6J Mice Fed High-fat Diets Supplemente...
 
Adiponektin
AdiponektinAdiponektin
Adiponektin
 
Health promoting properties encoded within fermented food microbiota
Health promoting properties encoded within fermented food microbiotaHealth promoting properties encoded within fermented food microbiota
Health promoting properties encoded within fermented food microbiota
 
Adipose tissue in immunity
Adipose tissue in immunityAdipose tissue in immunity
Adipose tissue in immunity
 
Inservice PERTS
Inservice PERTSInservice PERTS
Inservice PERTS
 
Adipose tissue hormones
Adipose tissue hormonesAdipose tissue hormones
Adipose tissue hormones
 
Insulin, glucagon and diabetes mellitus
Insulin, glucagon and diabetes mellitusInsulin, glucagon and diabetes mellitus
Insulin, glucagon and diabetes mellitus
 
Insulin
InsulinInsulin
Insulin
 

Andere mochten auch

Presentacin comunicacin oral
Presentacin comunicacin oralPresentacin comunicacin oral
Presentacin comunicacin oralAlberto Prz
 
Sepa workshop
Sepa workshopSepa workshop
Sepa workshopSuperp
 
Dr liu 12 8-2012 updike-risk management and pt assessment in pm
Dr liu 12 8-2012  updike-risk management and pt assessment in pmDr liu 12 8-2012  updike-risk management and pt assessment in pm
Dr liu 12 8-2012 updike-risk management and pt assessment in pmChau Nguyen
 
Dr liu 10 20-2012 anxiety
Dr liu 10 20-2012 anxietyDr liu 10 20-2012 anxiety
Dr liu 10 20-2012 anxietyChau Nguyen
 
Dr liu quit smoking slides 1 26-2013
Dr liu quit smoking slides 1 26-2013Dr liu quit smoking slides 1 26-2013
Dr liu quit smoking slides 1 26-2013Chau Nguyen
 

Andere mochten auch (8)

Presentacin comunicacin oral
Presentacin comunicacin oralPresentacin comunicacin oral
Presentacin comunicacin oral
 
Summer_catalogue_2014
Summer_catalogue_2014Summer_catalogue_2014
Summer_catalogue_2014
 
Sepa workshop
Sepa workshopSepa workshop
Sepa workshop
 
Gorivni kelii
Gorivni keliiGorivni kelii
Gorivni kelii
 
Dr liu 12 8-2012 updike-risk management and pt assessment in pm
Dr liu 12 8-2012  updike-risk management and pt assessment in pmDr liu 12 8-2012  updike-risk management and pt assessment in pm
Dr liu 12 8-2012 updike-risk management and pt assessment in pm
 
Dr liu 10 20-2012 anxiety
Dr liu 10 20-2012 anxietyDr liu 10 20-2012 anxiety
Dr liu 10 20-2012 anxiety
 
Sally breakfast
Sally breakfastSally breakfast
Sally breakfast
 
Dr liu quit smoking slides 1 26-2013
Dr liu quit smoking slides 1 26-2013Dr liu quit smoking slides 1 26-2013
Dr liu quit smoking slides 1 26-2013
 

Ähnlich wie An opportunistic pathogen isolated from the gut of

Probiotics for the Gut - A Guide for Primary Care Physicians
Probiotics for the Gut - A Guide for Primary Care PhysiciansProbiotics for the Gut - A Guide for Primary Care Physicians
Probiotics for the Gut - A Guide for Primary Care PhysiciansJarrod Lee
 
UROP Poster Jacob Jensen
UROP Poster Jacob JensenUROP Poster Jacob Jensen
UROP Poster Jacob JensenJacob Jensen
 
Role of GUT in PCOS
Role of GUT in PCOSRole of GUT in PCOS
Role of GUT in PCOSArunSharma10
 
The low FODMAP diet for irritable bowel syndrome: from evidence to practice
The low FODMAP diet for irritable bowel syndrome: from evidence to practice The low FODMAP diet for irritable bowel syndrome: from evidence to practice
The low FODMAP diet for irritable bowel syndrome: from evidence to practice Robin Allen
 
Microbiome and obesity
Microbiome and obesity Microbiome and obesity
Microbiome and obesity Erin Davis
 
Probiotics and Prebiotics
Probiotics and PrebioticsProbiotics and Prebiotics
Probiotics and Prebioticsmontica sawant
 
Colon Specific Drugs Delivary Systempptx
Colon Specific Drugs Delivary SystempptxColon Specific Drugs Delivary Systempptx
Colon Specific Drugs Delivary SystempptxHarshadaa bafna
 
Obesity and leptin...
Obesity and leptin...Obesity and leptin...
Obesity and leptin...Pulak Das
 
GITj club bloating.
GITj club bloating.GITj club bloating.
GITj club bloating.Shaikhani.
 
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...Norwich Research Park
 
Lobun Forte: Probiotics for CKD
Lobun Forte: Probiotics for CKDLobun Forte: Probiotics for CKD
Lobun Forte: Probiotics for CKDMedical Dialogues
 
Infogest george van aken final
Infogest george van aken finalInfogest george van aken final
Infogest george van aken finalGeorge van Aken
 
criteria of selecting probiotics (1).pptx
criteria of selecting probiotics (1).pptxcriteria of selecting probiotics (1).pptx
criteria of selecting probiotics (1).pptxMadiha Khan
 
Git j club fmt.
Git j club fmt.Git j club fmt.
Git j club fmt.Shaikhani.
 
"Probiotics: What Are They? What Can They Do for You?"
"Probiotics: What Are They? What Can They Do for You?""Probiotics: What Are They? What Can They Do for You?"
"Probiotics: What Are They? What Can They Do for You?"ibdsf00
 
Ibs-epidemiology in northern greece1.ppt
Ibs-epidemiology in northern greece1.pptIbs-epidemiology in northern greece1.ppt
Ibs-epidemiology in northern greece1.ppttahermostafa7
 

Ähnlich wie An opportunistic pathogen isolated from the gut of (20)

Probiotics for the Gut - A Guide for Primary Care Physicians
Probiotics for the Gut - A Guide for Primary Care PhysiciansProbiotics for the Gut - A Guide for Primary Care Physicians
Probiotics for the Gut - A Guide for Primary Care Physicians
 
UROP Poster Jacob Jensen
UROP Poster Jacob JensenUROP Poster Jacob Jensen
UROP Poster Jacob Jensen
 
Role of GUT in PCOS
Role of GUT in PCOSRole of GUT in PCOS
Role of GUT in PCOS
 
The low FODMAP diet for irritable bowel syndrome: from evidence to practice
The low FODMAP diet for irritable bowel syndrome: from evidence to practice The low FODMAP diet for irritable bowel syndrome: from evidence to practice
The low FODMAP diet for irritable bowel syndrome: from evidence to practice
 
Microbiome and obesity
Microbiome and obesity Microbiome and obesity
Microbiome and obesity
 
Probiotics and Prebiotics
Probiotics and PrebioticsProbiotics and Prebiotics
Probiotics and Prebiotics
 
Colon Specific Drugs Delivary Systempptx
Colon Specific Drugs Delivary SystempptxColon Specific Drugs Delivary Systempptx
Colon Specific Drugs Delivary Systempptx
 
Obesity and leptin...
Obesity and leptin...Obesity and leptin...
Obesity and leptin...
 
GITj club bloating.
GITj club bloating.GITj club bloating.
GITj club bloating.
 
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
 
Lobun Forte: Probiotics for CKD
Lobun Forte: Probiotics for CKDLobun Forte: Probiotics for CKD
Lobun Forte: Probiotics for CKD
 
Probiotics and prebiotics
Probiotics and prebioticsProbiotics and prebiotics
Probiotics and prebiotics
 
Infogest george van aken final
Infogest george van aken finalInfogest george van aken final
Infogest george van aken final
 
Probiotics&prebiotics
Probiotics&prebioticsProbiotics&prebiotics
Probiotics&prebiotics
 
Probiotics&prebiotic
Probiotics&prebioticProbiotics&prebiotic
Probiotics&prebiotic
 
criteria of selecting probiotics (1).pptx
criteria of selecting probiotics (1).pptxcriteria of selecting probiotics (1).pptx
criteria of selecting probiotics (1).pptx
 
Git j club fmt.
Git j club fmt.Git j club fmt.
Git j club fmt.
 
"Probiotics: What Are They? What Can They Do for You?"
"Probiotics: What Are They? What Can They Do for You?""Probiotics: What Are They? What Can They Do for You?"
"Probiotics: What Are They? What Can They Do for You?"
 
Probiotics
ProbioticsProbiotics
Probiotics
 
Ibs-epidemiology in northern greece1.ppt
Ibs-epidemiology in northern greece1.pptIbs-epidemiology in northern greece1.ppt
Ibs-epidemiology in northern greece1.ppt
 

Mehr von Chau Nguyen

Urinary tract infections
Urinary tract infections Urinary tract infections
Urinary tract infections Chau Nguyen
 
Lisa scientific facts of losing weight
Lisa scientific facts of losing weightLisa scientific facts of losing weight
Lisa scientific facts of losing weightChau Nguyen
 
Lisa heath nutrition diet and diabetes prevention lisa
Lisa heath nutrition diet and diabetes prevention lisaLisa heath nutrition diet and diabetes prevention lisa
Lisa heath nutrition diet and diabetes prevention lisaChau Nguyen
 
Dr liu life chinese version
Dr liu life chinese versionDr liu life chinese version
Dr liu life chinese versionChau Nguyen
 
Dr liu fibromyalgia disease overview-1
Dr liu fibromyalgia disease overview-1Dr liu fibromyalgia disease overview-1
Dr liu fibromyalgia disease overview-1Chau Nguyen
 
Dr liu diabetes community education
Dr liu diabetes community educationDr liu diabetes community education
Dr liu diabetes community educationChau Nguyen
 
Dr liu diabetes and pain
Dr liu diabetes and painDr liu diabetes and pain
Dr liu diabetes and painChau Nguyen
 
Dr liu depression
Dr liu depressionDr liu depression
Dr liu depressionChau Nguyen
 
Dr liu 1 19-2013 obesity
Dr liu 1 19-2013 obesity Dr liu 1 19-2013 obesity
Dr liu 1 19-2013 obesity Chau Nguyen
 
Chiamaka diabetes presentation
Chiamaka  diabetes presentationChiamaka  diabetes presentation
Chiamaka diabetes presentationChau Nguyen
 
A tiered approach to integrating genomic tests into
A tiered approach to integrating genomic tests intoA tiered approach to integrating genomic tests into
A tiered approach to integrating genomic tests intoChau Nguyen
 
12 22-2012 depression-2
12 22-2012 depression-212 22-2012 depression-2
12 22-2012 depression-2Chau Nguyen
 

Mehr von Chau Nguyen (17)

Urinary tract infections
Urinary tract infections Urinary tract infections
Urinary tract infections
 
Qysmia
QysmiaQysmia
Qysmia
 
Qsymia
QsymiaQsymia
Qsymia
 
Presentation 4
Presentation 4Presentation 4
Presentation 4
 
Presentation 3
Presentation 3Presentation 3
Presentation 3
 
Lisa scientific facts of losing weight
Lisa scientific facts of losing weightLisa scientific facts of losing weight
Lisa scientific facts of losing weight
 
Lisa heath nutrition diet and diabetes prevention lisa
Lisa heath nutrition diet and diabetes prevention lisaLisa heath nutrition diet and diabetes prevention lisa
Lisa heath nutrition diet and diabetes prevention lisa
 
Dr. lui j
Dr. lui jDr. lui j
Dr. lui j
 
Dr liu life chinese version
Dr liu life chinese versionDr liu life chinese version
Dr liu life chinese version
 
Dr liu fibromyalgia disease overview-1
Dr liu fibromyalgia disease overview-1Dr liu fibromyalgia disease overview-1
Dr liu fibromyalgia disease overview-1
 
Dr liu diabetes community education
Dr liu diabetes community educationDr liu diabetes community education
Dr liu diabetes community education
 
Dr liu diabetes and pain
Dr liu diabetes and painDr liu diabetes and pain
Dr liu diabetes and pain
 
Dr liu depression
Dr liu depressionDr liu depression
Dr liu depression
 
Dr liu 1 19-2013 obesity
Dr liu 1 19-2013 obesity Dr liu 1 19-2013 obesity
Dr liu 1 19-2013 obesity
 
Chiamaka diabetes presentation
Chiamaka  diabetes presentationChiamaka  diabetes presentation
Chiamaka diabetes presentation
 
A tiered approach to integrating genomic tests into
A tiered approach to integrating genomic tests intoA tiered approach to integrating genomic tests into
A tiered approach to integrating genomic tests into
 
12 22-2012 depression-2
12 22-2012 depression-212 22-2012 depression-2
12 22-2012 depression-2
 

An opportunistic pathogen isolated from the gut of

  • 1. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice Lisa Luna Medical Primary Care
  • 2. Case • weight 174.8 kg, • body mass index 58.8 kgm2 • suffering from diabetes, hypertension and other serious metabolic deteriorations • on a diet composed of whole grains, traditional Chinese medicinal foods and prebiotics • lost 30.1 kg after 9 weeks, and 51.4 kg after 23 weeks • Amelioration of hyperinsulinemia, hyperglycemia and hypertension until most metabolic parameters improved to normal ranges
  • 3. How does it happen? • Biomedical Indicator
  • 4. Key Point----Enterobacter a genus of opportunistic, endotoxin producing Pathogens, made up 35% of the gut bacteria in a morbidly obese volunteer After 9 weeks on the WTP diet*, this Enterobacter population in the volunteer’s gut reduced to 1.8%, and became undetectable by the end of the 23-week trial *WTP Diet :whole grains, traditional Chinese medicine and prebiotics
  • 5. Hypothesis The endotoxin producing Enterobacter population may have a causative role in the metabolic deteriorations of its human host
  • 6. Animal Studies Animal: Germfree (GF) male C57BL/6J mice* *germfree mice are resistant to HFD-induced obesity Clinical isolation: • Strain Enterobacter cloacae B29 isolated from the volunteer’s gut • and nearest neighbor as E.cloacae subsp. cloacae ATCC 13047 Process: Inoculation of B29 and Luria–Bertani (LB) into GF mice Feed: • normal chow diet (NCD) or • High fat diet(HFD)
  • 7. (continued) 4 groups: • NCD+B29 • NCD+LB • HFD+B29 • HFD+LB data collected at the end of 16 weeks after inoculation • Body weight • mass of epididymal, mesenteric, subcutaneous inguinal and retroperitoneal fat pad; • oral glucose tolerance test (OGTT) and areas under the curve (AUC) for the plasma glucose; • serum 2h post load insulin; • enzyme-linked immunosorbent assay (ELISA) analysis of serum LPS-binding protein (LBP); • serum amyloid A (SAA); • adiponectin corrected for bodyweight
  • 8. Body weight after 16 weeks of experiment
  • 9. Fat pad after 16 weeks of experiment
  • 10. Blood Glucose level after 16 weeks of experiment
  • 11. Conclusion from the data collected • The HFD+B29 gnotobiotic mice developed the most significant insulin resistant phenotype and body gain and other characteristics of obesity • The NCD+B29or NCD+LB both remained lean throughout the trial
  • 12. Serum LPS-binding protein after 16 weeks *B29 was the only LPS producer in the gnotobiotic-mouse gut
  • 13. Conclusion from the LBP level after 16 weeks experiment • The serum LPS-binding protein was significantly higher in the HFD+B29 gnotobiotic mice than in the NCD+B29 • increased serum–endotoxin load in the HFD+B29 gnotobiotic mice could only come from B29.
  • 14. Serum SAA and adiponection level after the 16 weeks HFD+B29 mice had the greatest increase in systemic inflammation
  • 15. Conclusion of the study Overgrowth of an endotoxin producing gut bacterium is a contributing factor to, rather than a consequence of, the metabolic deteriorations in its human host
  • 16. Strength of the study • for the first time, established a gnotobiotic-mouse obesity model combining HFD with a human-originated endotoxin producer • identify more such obesity-inducing bacteria from various human populations • develop new strategies for reducing the devastating epidemic of metabolic diseases
  • 17. Several question remains uncertain • Study is conducted for 16 weeks, it’s uncertain if the gut pathogen from the obese functions the similar way in a long term. • B29 is probably not the only contributor to human obesity in vivo. • More case study is required to replicate the experiments
  • 18. Thank You! We Appreciate Your Patience